Supreme Court Agrees To Hear Generic Reglan Drug Label Suit
|
|
Last Modified
on
Mar 16, 2024
The U.S. Supreme Court has agreed to hear arguments over whether generic drug makers can be sued for the failure to warn about dangerous side effects on their drug label even when they follow federal rules. In PLIVA, Inc. v. Mensing a woman took metoclopramide – the generic equivalent of Reglan – for four years… read more
Manufacturers of dangerous drugs should not be immune from liability
|
|
Last Modified
on
May 02, 2024
The Sixth Circuit Court of Appeals has recently submitted a question to the Food and Drug Administration requesting a response to its position on immunity. At issue is the claim by manufacturers that because the FDA regulates prescription drugs, once the drugs they make have received FDA “approval,” drug manufacturers cannot be held liable for… read more
DANGEROUS DRUG – Reglan
|
|
Last Modified
on
Mar 16, 2024
Reglan is a prescription drug pushed by pharmaceutical companies to patients to treat Gastroesophageal reflux (GER) Gastroesophageal reflux disease (GERD). Many studies dating back from the 1970s have shown that Reglan is ineffective in resolving GER and GERD. A 2006 study published in Nature Clinical Practice: Gastroenterology & Hepatology concluded that “the evidence base for… read more